Evidence map›Paper›PMID 32512787›Full record

ReviewNutrients2020

Health Benefits of Lactic Acid Bacteria (LAB) Fermentates.

Harsh Mathur, Tom P Beresford, Paul D Cotter

Abstract readReview
In one paragraph

Review in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Pharmaceutics · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Expression of Enterocin A in Saccharomyces cerevisiae.Probiotics and antimicrobial proteins · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. AGut microbiome (Cambridge, England) · 2026
    Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Harsh MathurFood for Health Ireland, Teagasc Food Research Centre, Moorepark, Fermoy, P61 C996 Co. Cork, Ireland.
Tom P BeresfordFood for Health Ireland, Teagasc Food Research Centre, Moorepark, Fermoy, P61 C996 Co. Cork, Ireland.
Paul D CotterFood for Health Ireland, Teagasc Food Research Centre, Moorepark, Fermoy, P61 C996 Co. Cork, Ireland.

Funding

Food for Health Ireland (FHI) through Enterprise Ireland and Industry TC/2018/0025.
6 · The paper itself

Abstract

Consuming fermented foods has been reported to result in improvements in a range of health parameters. These positive effects can be exerted by a combination of the live microorganisms that the fermented foods contain, as well as the bioactive components released into the foods as by-products of the fermentation process. In many instances, and particularly in dairy fermented foods, the microorganisms involved in the fermentation process belong to the lactic acid group of bacteria (LAB). An alternative approach to making some of the health benefits that have been attributed to fermented foods available is through the production of 'fermentates'. The term 'fermentate' generally relates to a powdered preparation, derived from a fermented product and which can contain the fermenting microorganisms, components of these microorganisms, culture supernatants, fermented substrates, and a range of metabolites and bioactive components with potential health benefits. Here, we provide a brief overview of a selection of in vitro and in vivo studies and patents exclusively reporting the health benefits of LAB 'fermentates'. Typically, in such studies, the potential health benefits have been attributed to the bioactive metabolites present in the crude fermentates and/or culture supernatants rather than the direct effects of the LAB strain(s) involved.

Indexed as

Fermented FoodsFood MicrobiologyLactobacillalesProbioticsAngiotensin-Converting Enzyme InhibitorsAntioxidantsCardiovascular DiseasesCognitionCultured Milk ProductsDiabetes Mellitus, Type 2FermentationFoodborne DiseasesGastrointestinal MicrobiomeHumansImmunomodulationNutritional Physiological PhenomenaAngiotensin-Converting Enzyme InhibitorsAntioxidantsantimicrobialfermentatesguthealth effectsimmunomodulationlactic acid bacteria (LAB)

Identifiers

PMID32512787
PMCPMC7352953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.